SEC Form 4 · accession 0001127602-18-000928
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Jan 6, 2016
Accepted (ET)
Jan 4, 2018 · 11:09 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 6, 2016 | G | 6,250 | $0.00 | D | 329,928 | D | |
| Common Stock | Apr 12, 2016 | G | 5,000 | $0.00 | D | 324,928 | D | |
| Common Stock | Jun 27, 2017 | G | 2,162 | $0.00 | D | 322,766 | D | |
| Common Stock | Sep 20, 2017 | G | 2,500 | $0.00 | D | 320,266 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.12 | D | 320,166 | D | |
| Common Stock | Jan 2, 2018 | S | 600 | $109.18 | D | 319,566 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.25 | D | 319,366 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.35 | D | 319,166 | D | |
| Common Stock | Jan 2, 2018 | S | 477 | $109.36 | D | 318,689 | D | |
| Common Stock | Jan 2, 2018 | S | 2 | $109.435 | D | 318,687 | D | |
| Common Stock | Jan 2, 2018 | S | 198 | $109.445 | D | 318,489 | D | |
| Common Stock | Jan 2, 2018 | S | 500 | $109.45 | D | 317,989 | D | |
| Common Stock | Jan 2, 2018 | S | 90 | $109.465 | D | 317,899 | D | |
| Common Stock | Jan 2, 2018 | S | 400 | $109.50 | D | 317,499 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.51 | D | 317,299 | D | |
| Common Stock | Jan 2, 2018 | S | 700 | $109.52 | D | 316,599 | D | |
| Common Stock | Jan 2, 2018 | S | 300 | $109.53 | D | 316,299 | D | |
| Common Stock | Jan 2, 2018 | S | 10 | $109.55 | D | 316,289 | D | |
| Common Stock | Jan 2, 2018 | S | 109 | $109.555 | D | 316,180 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.58 | D | 316,080 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.585 | D | 315,980 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.59 | D | 315,880 | D | |
| Common Stock | Jan 2, 2018 | S | 191 | $109.595 | D | 315,689 | D | |
| Common Stock | Jan 2, 2018 | S | 90 | $109.60 | D | 315,599 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $109.61 | D | 315,399 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $109.63 | D | 315,299 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.